Evidence map›Paper›PMID 25229454›Full record

ArticlePloS one2014

Epigenetic mechanisms underlying the dynamic expression of cancer-testis genes, PAGE2, -2B and SPANX-B, during mesenchymal-to-epithelial transition.

Sinem Yilmaz-Ozcan, Asli Sade, Baris Kucukkaraduman, Yasemin Kaygusuz, Kerem Mert Senses, Sreeparna Banerjee, Ali Osmay Gure

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. PeerJ · 2020
    Article
  9. Article
  10. Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Sinem Yilmaz-OzcanDepartment of Molecular Biology and Genetics, Bilkent University, Ankara, Turkey.
Asli SadeDepartment of Biological Sciences, Middle East Technical University, Ankara, Turkey.
Baris KucukkaradumanDepartment of Molecular Biology and Genetics, Bilkent University, Ankara, Turkey.
Yasemin KaygusuzDepartment of Molecular Biology and Genetics, Bilkent University, Ankara, Turkey.
Kerem Mert SensesDepartment of Molecular Biology and Genetics, Bilkent University, Ankara, Turkey.
Sreeparna BanerjeeDepartment of Biological Sciences, Middle East Technical University, Ankara, Turkey.
Ali Osmay GureDepartment of Molecular Biology and Genetics, Bilkent University, Ankara, Turkey.
Bilkent University · TRMiddle East Technical University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cancer-testis (CT) genes are expressed in various cancers but not in normal tissues other than in cells of the germline. Although DNA demethylation of promoter-proximal CpGs of CT genes is linked to their expression in cancer, the mechanisms leading to demethylation are unknown. To elucidate such mechanisms we chose to study the Caco-2 colorectal cancer cell line during the course of its spontaneous differentiation in vitro, as we found CT genes, in particular PAGE2, -2B and SPANX-B, to be up-regulated during this process. Differentiation of these cells resulted in a mesenchymal-to-epithelial transition (MET) as evidenced by the gain of epithelial markers CDX2, Claudin-4 and E-cadherin, and a concomitant loss of mesenchymal markers Vimentin, Fibronectin-1 and Transgelin. PAGE2 and SPAN-X up-regulation was accompanied by an increase in Ten-eleven translocation-2 (TET2) expression and cytosine 5-hydroxymethylation as well as the disassociation of heterochromatin protein 1 and the polycomb repressive complex 2 protein EZH2 from promoter-proximal regions of these genes. Reversal of differentiation resulted in down-regulation of PAGE2, -2B and SPANX-B, and induction of epithelial-to-mesenchymal transition (EMT) markers, demonstrating the dynamic nature of CT gene regulation in this model.

Indexed as

Epigenesis, GeneticAntigens, NeoplasmCell DifferentiationCell Line, TumorCell TransdifferentiationChromobox Protein Homolog 5Chromosomal Proteins, Non-HistoneDioxygenasesDNA-Binding ProteinsEnhancer of Zeste Homolog 2 ProteinEpithelial-Mesenchymal TransitionHumansNuclear ProteinsPolycomb Repressive Complex 2Promoter Regions, GeneticProto-Oncogene ProteinsAntigens, NeoplasmChromobox Protein Homolog 5Chromosomal Proteins, Non-HistoneDioxygenasesDNA-Binding ProteinsEnhancer of Zeste Homolog 2 ProteinEZH2 protein, humanNuclear ProteinsPAGE2 protein, humanPolycomb Repressive Complex 2Proto-Oncogene ProteinsSPANXB1 protein, humanTET2 protein, human

Identifiers

PMID25229454
PMCPMC4168264
OpenAlexW2130742607

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.